| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 04/11/2002 | WO2002028865A2 Condensed pyridoindole derivatives |
| 04/11/2002 | WO2002028858A2 Hexahydropyrazino `1'2' : 1, 6!- pyrido `3, 4-b! indole-1, 4-dione derivatives for the treatment of cardiovascular disorders and erectile disfunction |
| 04/11/2002 | WO2002028836A1 Novel crystalline forms of a factor xa inhibitor |
| 04/11/2002 | WO2002028830A1 Novel phenylalanine derivatives |
| 04/11/2002 | WO2002028827A1 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation |
| 04/11/2002 | WO2002028825A2 Aminopyridinyl-, aminoguanidinyl- and alkoxyguanidinyl- substituted phenyl acetamides as protease inhibitors |
| 04/11/2002 | WO2002028823A1 Malonamid and malonamic ester derivatives with antithrombotic activity, their preparation and their use |
| 04/11/2002 | WO2002028433A2 Use of a ppar delta activator in the treatment of diseases related to no inhibit ion or tnf inhibition |
| 04/11/2002 | WO2002028416A1 Preventives/remedies for hemolytic anemia |
| 04/11/2002 | WO2002028347A2 Derivatives of tryptamine and analogous compounds, and pharmaceutical formulations containing them |
| 04/11/2002 | WO2001092308A3 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 04/11/2002 | WO2001090070A3 Caspase inhibitors and uses thereof |
| 04/11/2002 | WO2001087342A3 Delivery devices for treatment of vascular disease |
| 04/11/2002 | WO2001085671A3 Anthranyl amides and their use as medicaments |
| 04/11/2002 | WO2001082868A3 A medicinal aerosol formulation |
| 04/11/2002 | WO2001077079A3 Polycyclic aryl and heteroaryl substituted 4-pyridones useful for selective inhibition of the coagulation cascade |
| 04/11/2002 | WO2001076572A3 Use of compatible solutes as substances having free radical scavenging properties |
| 04/11/2002 | WO2001075107A3 Use of p-selectin glycoprotein ligand-1 (psgl-1) and fragments thereof for the inhibition of thrombosis |
| 04/11/2002 | WO2001066085A3 Micellar pharmaceutical compositions for buccal and pulmonary application |
| 04/11/2002 | WO2001036616A3 Acid nucleic construct bearing a system regulating the expression of a gene |
| 04/11/2002 | US20020042421 Antiinflammatory agents |
| 04/11/2002 | US20020042415 Dipeptide derivatives |
| 04/11/2002 | US20020042405 Epoxy-steroidal aldosterone antagonist and calcium channel blocker combination therapy for treatment of congestive heart failure |
| 04/11/2002 | US20020042396 Amino acid derivatives |
| 04/11/2002 | US20020042376 Antiinflammatory agents; autoimmune disease; antiischemic agents |
| 04/11/2002 | US20020042372 Genetic engineering; central nervous system disorders |
| 04/11/2002 | US20020042368 Integrin antagonists |
| 04/11/2002 | US20020042144 Preventing agglomeration of bodily fluid; obtain body fluid sample, incubate with enzyme inhibitors, monitor body fluid agglomeration |
| 04/11/2002 | US20020042130 Propagating preferential aggregations; obtain aggregation, incubate with buffy coat cells, propagate, recover genetically engineered cells |
| 04/11/2002 | US20020042128 Electroprocessed fibrin-based matrices and tissues |
| 04/11/2002 | US20020042091 Methods and compositions for screening modulators of lipid kinases |
| 04/11/2002 | US20020042043 Preparation of a pathogen inactivated solution of red blood cells having reduced immunogenicity |
| 04/11/2002 | DE10049937A1 New sugar-modified amidine and guanidine compounds, useful as competitive inhibitors of serine protease, e.g. for treating thrombosis |
| 04/11/2002 | CA2425269A1 G-protein coupled receptors |
| 04/11/2002 | CA2425169A1 Hematopoietin receptors hpr1 and hpr2 |
| 04/11/2002 | CA2425126A1 Lipid metabolism enzymes |
| 04/11/2002 | CA2424199A1 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 04/11/2002 | CA2423929A1 Carbohydrate-associated proteins |
| 04/11/2002 | CA2423883A1 Aminopyridinyl-, aminoguanidinyl- and alkoxyguanidinyl- substituted phenyl acetamides as protease inhibitors |
| 04/11/2002 | CA2423677A1 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins |
| 04/11/2002 | CA2423462A1 Nectin polypeptides, polynucleotides, methods of making and use thereof |
| 04/11/2002 | CA2423312A1 Condensed pyridoindole derivatives |
| 04/10/2002 | EP1195605A1 Methods and compositions for screening modulators of lipid kinases |
| 04/10/2002 | EP1195604A1 Methods and compositions for screening modulators of lipid kinases |
| 04/10/2002 | EP1195440A1 Gene delivery vectors for stem cells |
| 04/10/2002 | EP1195384A1 Snake proteins having antithrombotic activity |
| 04/10/2002 | EP1195166A2 Use of a vasopressin antagonist such as conivaptan in the manufacture of a medicament for treating pulmonary hypertension |
| 04/10/2002 | EP1195163A1 Serine protease inhibitor |
| 04/10/2002 | EP1194552A1 Nucleic acids coding for peptides having the biological activity of sorbin |
| 04/10/2002 | EP1194547A2 Cdna sequences of two interacting fancip2 and fancip3 of the fanconi anemia complementation group a protein |
| 04/10/2002 | EP1194543A2 HUMAN PROTEINS HAVING HYDROPHOBIC DOMAINS AND DNAs ENCODING THESE PROTEINS |
| 04/10/2002 | EP1194528A1 Ligands for use in therapeutic compositions for the treatment of hemostasis disorders |
| 04/10/2002 | EP1194448A1 Seven transmembrane receptor genes |
| 04/10/2002 | EP1194441A2 Thiophene a2a receptor agonists |
| 04/10/2002 | EP1194428A1 Heteroaryl protease inhibitors and diagnostic imaging agents |
| 04/10/2002 | EP1194409A1 Pyrazolidinol compounds |
| 04/10/2002 | EP1194401A1 Diacylhydrazine derivatives |
| 04/10/2002 | EP1194174A2 Extending the lifetime of anticoagulant oligodeoxynucleotide aptamers in blood |
| 04/10/2002 | EP1194167A1 Immunotherapy of autoimmune disorders using antibodies which target b-cells |
| 04/10/2002 | EP1194161A1 Stable factor viii compositions |
| 04/10/2002 | EP1194140A1 Pharmaceutical composition containing fenofibrate and preparation method |
| 04/10/2002 | EP1030845B1 Heterocyclic compounds having mmp and tnf inhibitory activity |
| 04/10/2002 | EP0863916B1 Polyfluoroalkyl tryptophan tripeptide thrombin inhibitors |
| 04/10/2002 | CN1344326A Petroviral vectors comprising functional and non-functional splice donor and splce acceptor sites |
| 04/10/2002 | CN1344318A Protein for blocking platelet adhesion |
| 04/10/2002 | CN1344256A (Hetero) aryl-bicyclic heteroaryl derivatives, their prepn. and their use as protease inhibitors |
| 04/10/2002 | CN1344249A 酰胺衍生物 Amide derivatives |
| 04/10/2002 | CN1344155A Transnasal transport/immunisation with highly adaptable carriers |
| 04/10/2002 | CN1343663A Amlodipine-series salts and preparing process and application thereof |
| 04/09/2002 | US6369227 Thrombin or factor Xa inhibitors |
| 04/09/2002 | US6369210 22012, human carboxypeptidase |
| 04/09/2002 | US6369193 Contulakin-G, analogs thereof and uses therefor |
| 04/09/2002 | US6369165 Method for the production of polymers from n-vinyl compounds |
| 04/09/2002 | US6369099 Method of locking 1 α-OH of vitamin D compounds in axial orientation |
| 04/09/2002 | US6369089 Interheteroaryl 7-oxabicyclic [2.2.1]heptane oxazoles as prostaglandin F2α antagonists |
| 04/09/2002 | US6369086 Substituted oxidole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors |
| 04/09/2002 | US6369084 Prostaglandin mediated diseases |
| 04/09/2002 | US6369082 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 04/09/2002 | US6369080 Anticoagulant |
| 04/09/2002 | US6369064 Triazolo(4,5-d)pyrimidine compounds |
| 04/09/2002 | US6369063 Selective factor Xa inhibitors |
| 04/09/2002 | US6369031 Administering to combination of human protein z and human protein z-dependent protease inhibitor (zpi) to inhibit factor xa formation |
| 04/09/2002 | CA2298572C Deuterated cyclosporine analogs and their use as immunomodulating agents |
| 04/09/2002 | CA2263800C A thrombin blood fraction for use in a medical procedure |
| 04/09/2002 | CA2233698C Polyfluoroalkyl tryptophan tripeptide thrombin inhibitors |
| 04/09/2002 | CA1341355C Production and use of il-6 |
| 04/04/2002 | WO2002027318A1 Methods and compositions for screening modulators of lipid kinases |
| 04/04/2002 | WO2002026946A2 Fad4, fad5, fad5-2, and fad6, fatty acid desaturase family members and uses thereof |
| 04/04/2002 | WO2002026825A2 G-protein coupled receptors |
| 04/04/2002 | WO2002026781A2 Ige receptor antagonists |
| 04/04/2002 | WO2002026774A2 Melanocortin receptor ligands |
| 04/04/2002 | WO2002026752A1 α-SUBSTITUTED β-AMINOETHYL PHOSPHONATES |
| 04/04/2002 | WO2002026734A1 PIPERAZIN-2-ONE AMIDES AS INHIBITORS OF FACTOR Xa |
| 04/04/2002 | WO2002026731A2 Quaternary amidino based inhibitors of factor xa |
| 04/04/2002 | WO2002026729A2 Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders |
| 04/04/2002 | WO2002026727A2 Methods of providing and using compounds (retinoids) having activity as inhibitors of cytochrome p450rai |
| 04/04/2002 | WO2002026723A1 Compounds useful in the treatment of inflammatory diseases |
| 04/04/2002 | WO2002026720A2 PIPERAZINE BASED INHIBITORS OF FACTOR Xa |
| 04/04/2002 | WO2002026718A2 Bicyclic pyrimidin-4-one based inhibitors of factor xa |
| 04/04/2002 | WO2002026712A2 Quaternary amines and related inhibitors of factor xa |